0001181431-13-052504.txt : 20131003
0001181431-13-052504.hdr.sgml : 20131003
20131003205021
ACCESSION NUMBER: 0001181431-13-052504
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131001
FILED AS OF DATE: 20131003
DATE AS OF CHANGE: 20131003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001012140
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943154463
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 249 E. GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-266-0000
MAIL ADDRESS:
STREET 1: 249 E. GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GODDARD PAUL
CENTRAL INDEX KEY: 0001227124
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28298
FILM NUMBER: 131135334
MAIL ADDRESS:
STREET 1: ADOLOR CORPORATION
STREET 2: 700 PENNSYLVANIA DR.
CITY: EXTON
STATE: PA
ZIP: 19341
4
1
rrd392203.xml
FORM 4
X0306
4
2013-10-01
1
0001012140
ONYX PHARMACEUTICALS INC
ONXX
0001227124
GODDARD PAUL
C/O ONYX PHARMACEUTICALS, INC.
249 E. GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2013-10-01
4
U
0
12790
125.00
D
2100
D
Common Stock
2013-10-01
4
D
0
2100
125.00
D
0
D
Stock Options
28.41
2013-10-01
4
D
0
1000
0
D
2006-02-07
2015-02-07
Common Stock
1000
0
D
Stock Options
26.69
2013-10-01
4
D
0
10000
0
D
2007-02-07
2016-02-07
Common Stock
10000
0
D
Stock Options
45.09
2013-10-01
4
D
0
10000
0
D
2009-02-07
2018-02-07
Common Stock
10000
0
D
Stock Options
28.55
2013-10-01
4
D
0
5726
0
D
2010-03-31
2019-03-31
Common Stock
5726
0
D
Stock Options
30.28
2013-10-01
4
D
0
5000
0
D
2011-03-31
2020-03-31
Common Stock
5000
0
D
Stock Options
35.18
2013-10-01
4
D
0
5000
0
D
2012-03-31
2021-03-31
Common Stock
5000
0
D
Stock Options
37.68
2013-10-01
4
D
0
5000
0
D
2013-03-30
2022-03-30
Common Stock
5000
0
D
Stock Options
76.79
2013-10-01
4
D
0
2000
0
D
2013-07-25
2022-07-25
Common Stock
2000
0
D
Stock Options
88.86
2013-10-01
4
D
0
5900
0
D
2014-03-28
2023-03-27
Common Stock
5900
0
D
These restricted stock awards were cancelled at the effective time of the merger (the "Merger") pursuant to the Agreement and Plan of Merger, dated August 24, 2013, by and among Onyx Pharmaceuticals, Inc. ("Onyx"), Amgen Inc. and Arena Acquisition Company (the "Merger Agreement") in exchange for an aggregate cash payment equal to the number of shares of Onyx's common stock underlying such restricted stock awards multiplied by the per share purchase price of $125.00.
Represents options to purchase Onyx's common stock that were subject to vesting over time but were cancelled in the Merger in exchange for a cash payment in the amount by which the per share purchase price of $125.00 exceeded the exercise price of the option as of the effective time of the Merger.
/s/ Matthew K. Fust, Attorney-in-fact
2013-10-03